Data shown is for informational purposes only and does not constitute investment advice. TopFund is not SEBI-registered. Consult a SEBI-registered advisor before investing.
UTI Medium Duration Fund - Regular Plan - Growth Option
★★★★★ TopFund est.
TopFund Score (fallback rating)
- Calculated by: TopFund — used only when no third-party rating exists for this fund
- Formula: 3-year trailing return percentile within category, adjusted ±1 star for expense ratio
- Refresh frequency: Whenever TopFund re-syncs this fund's data
- Limitations: A simplified 2-factor estimate, not equivalent to a rating agency's full analysis
TopFund Score: 44/100 · Weak
How this score is calculated
- Star rating (35%)2/5
- 3Y CAGR (30%)6.31%
- Expense ratio (20%)1.29%
- AUM (15%)₹302 Cr
Not investment advice — an analytical read of public fund data. Methodology →
UTI Mutual Fund · Income/Debt Oriented · Medium Term Fund
₹19.22
AUM: ₹302 Cr
NAV updated 13 days ago
Plan
Regular
Option
Growth
Risk
Moderate
Expense Ratio
1.29%
Exit Load
Nil
Fund Manager
Amandeep Chopra
Inception
Jan 2013
Benchmark
CRISIL Medium to Long Duration Debt A-III Index
Sharpe Ratio
-1.25
Std Dev (1Y)
1.38%
Historical Returns (CAGR)
Annualized trailing returns computed from NAV history — past performance only, not a guarantee of future results.
1m
-0.21%
3m
+1.36%
6m
+2.1%
1y
+4.55%
3y
+6.31%
5y
+5.95%
10y
+5.35%
since inception
+5.88%
TopFund's Take on UTI Medium Duration Fund - Regular Plan - Growth Option
UTI Medium Duration Fund - Regular Plan - Growth Option lags behind most of its peers in the Medium Term Fund category, currently carrying a 2-star rating. TopFund's composite Health Score, which weighs rating, 3-year CAGR, expense ratio and fund size, puts it at 44/100.
Cost: At 1.29%, the expense ratio runs 74% above the Medium Term Fund category average of 0.74%. That gap is worth weighing against the fund's actual performance versus cheaper peers before committing to a long SIP.
Risk-adjusted performance: Over the trailing 1-year period, the fund shows a negative Sharpe ratio of -1.25 — over the past year, returns haven't kept pace with the volatility involved, even before accounting for the risk-free rate. Separately, annualised volatility of 1.38% is on the lower side for a Medium Term Fund fund, suggesting a comparatively smoother ride.
Who should invest: This fund is best suited to investors whose goals and risk appetite align with a Income/Debt Oriented fund.
This is an automated, data-driven analysis based on the fund's own metrics and its category peers — not personalized investment advice. Consult a SEBI-registered advisor before investing.
Sector Allocation
Asset Allocation
Fund Snapshot
Tools & Guides for This Fund
Frequently Asked Questions about UTI Medium Duration Fund - Regular Plan - Growth Option
The current NAV (Net Asset Value) of UTI Medium Duration Fund - Regular Plan - Growth Option is ₹19.22. NAV is updated every business day after market close by AMFI.
1Y: 4.55% · 3Y CAGR: 6.31% · 5Y CAGR: 5.95%
The expense ratio of UTI Medium Duration Fund - Regular Plan - Growth Option is 1.29% per annum. This is the annual fee charged by the fund to manage your investment.
UTI Medium Duration Fund - Regular Plan - Growth Option is managed by Amandeep Chopra at UTI Mutual Fund.
UTI Medium Duration Fund - Regular Plan - Growth Option is classified as a Moderate risk fund. It is suitable for investors with a moderate risk appetite.
UTI Medium Duration Fund - Regular Plan - Growth Option is a Medium Term Fund fund. SIP suitability depends on your investment goal and risk profile.
You can start a SIP in UTI Medium Duration Fund - Regular Plan - Growth Option with as little as ₹500 per month through most mutual fund platforms. The minimum lump sum investment is typically ₹1,000.
The Assets Under Management (AUM) of UTI Medium Duration Fund - Regular Plan - Growth Option is ₹302 crore. AUM indicates the total market value of assets managed by the fund.
* Past performance is not indicative of future results. Mutual fund investments are subject to market risks.
Discussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
No comments yet — start the discussion.